// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























4759 Abstracts

Rociletinib-associated cataracts in EGFR-mutant NSCLC.

Zofia Piotrowska - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Hyperglycemia

rociletinib

Metabolic status of BRCA1 mutation carriers.

Olga Ivanov - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Caffeine

Survival and glycemic control in patients with colorectal cancer and diabetes mellitus.

Nina J. Karlin - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Implications of melanoma with diabetes mellitus on patient outcomes.

Nina J. Karlin - American Society of Clinical Oncology (ASCO) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Cancer patients with undiagnosed and poorly managed diabetes mellitus.

Sooha Kim - American Society of Clinical Oncology (ASCO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Hyperglycemia and survival in solid tumors: A systematic review and meta-analysis.

Reeta Barua - American Society of Clinical Oncology (ASCO) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Type 2 diabetes and glycemic traits in relation to colorectal cancer risk: A Mendelian randomization study

Mingyang Song - American Association for Cancer Research (AACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Trends in the quality of preventive care before and after prostate cancer diagnosis.

Lauren P. Wallner - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Evaluation of possible prognostic factors in patients with acute myeloid leukemia (univariate and multivariate analysis).

Mohamed Abdelfatah - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute myelocytic leukemia

N/A

Results of SARC 022, a phase II multicenter study of linsitinib in pediatric and adult wild-type (WT) gastrointestinal stromal tumors (GIST).

Margaret von Mehren - American Society of Clinical Oncology (ASCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastrointestinal stromal tumor

Linsitinib

A multidisciplinary clinic to mitigate the impact of androgen deprivation therapy in prostate cancer: A pilot study.

Rahul Raj Aggarwal - American Society of Clinical Oncology Genitourinary (ASCO GU) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

Androgen Tear

A phase II trial of neoadjuvant aromatase inhibitor therapy and the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and a low/intermediate risk Oncotype Dx Recurrence Score (? 25).

Maysa M. Abu-Khalaf - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diabetes

Anastrozole

Factors influencing telomere length in BRCA-mutation carriers.

Emer M. Guinan - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A case of copper deficiency myelopathy with features of Parkinsonism and brain iron accumulation

Sergio Montes - International Congress of Parkinson's Disease and Movement Disorders (MDS) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Aceruloplasminemia

Cyanocobalamin

Hyperglycemia among hospitalized cancer patients with co-existing diabetes mellitus.

Nina J. Karlin - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diabetes

N/A

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting for gynecological cancer: KCOG G-1301 phase II trial.

Masakazu Abe - American Society of Clinical Oncology (ASCO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Chemotherapy-induced nausea and vomiting

Dexamethasone

The association of serum albumin and glycated hemoglobin with all cause mortality in patients with breast cancer

Minocha VN - San Antonio Breast Cancer Symposium (SABCS) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

The Assessment of Interaction of Chronic Hyperglycemia on the Relationship Between Hypoglycemia and Mortality in Critically Ill Patients

Moritoki Egi - American Society of Anesthesiologists (ASA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperglycemia

N/A

Oxidative Stress Leads to Altered Gene Expression in Cardiac Myocytes Following Cardiopulmonary Bypass in Patients with Poorly Controlled Type II Diabetes vs. Non-Diabetics

Jeffrey Hubbard - American Society of Anesthesiologists (ASA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

The Effect of Elevated Glyco-Hemoglobin (HbA1C) on Postoperative Morbidity: A Prospective Observational Study

Pinxia Chen - American Society of Anesthesiologists (ASA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved